Alternation in the Human Microbiome With Commonly Used Topical Medications
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Feb 12, 2018
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how commonly used creams, like antifungals and low-potency steroids, might change the bacteria and other microorganisms living on our skin, known as the skin microbiome. Specifically, researchers want to find out if using ketoconazole cream, which treats fungal infections, or desonide ointment, a mild steroid for skin conditions, affects the skin microbiome over a short period of time.
To participate in this study, you need to be an adult aged 18 or older and generally healthy. However, people with certain skin diseases, recent use of antibiotics, or known allergies to the medications being tested won’t be eligible. If you join the study, you will use one of the creams and then provide samples to help researchers see if and how your skin microbiome changes. This study is important as it helps us understand the effects of common skin treatments on our skin's natural bacteria, which could lead to better skincare practices in the future.
Gender
ALL
Eligibility criteria
- The inclusion criteria:
- • • Adults at least 18 years of age.
- The exclusion criteria:
- • Individuals with known chronically active skin diseases, including atopic dermatitis, psoriasis, seborrheic dermatitis, other autoimmune and inflammatory skin conditions.
- • Patients with a history of skin cancer, multiple nevi, or other isolated lesions will not be excluded.
- • Individuals who have used topical, intravenous, intramuscular, or oral antibiotics within the last 6 months
- • Individuals with known allergies to any of the study medications.
- • Individuals younger than 18 years of age.
- • Adults unable to consent
- • Non-English speaking individuals. Given the complexity in the instructions that subjects will need to follow for proper sample collection, we will not seek to recruit non-English speaking individuals for this pilot study.
- • Prisoners
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Emanual Maverakis, MD
Principal Investigator
UC Davis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials